Chronic kidney disease linked with spontaneous intracerebral hemorrhage, finds JAMA study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-08-22 14:30 GMT   |   Update On 2022-08-22 14:30 GMT

A causal association exists between chronic kidney disease and spontaneous intracerebral haemorrhage according to a recent study published in the JAMA Neurology. The evidence linking chronic kidney disease (CKD) to spontaneous intracerebral haemorrhage (ICH) is inconclusive owing to possible confounding by comorbidities that frequently coexist in patients with these 2 diseases. A...

Login or Register to read the full article

A causal association exists between chronic kidney disease and spontaneous intracerebral haemorrhage according to a recent study published in the JAMA Neurology.

The evidence linking chronic kidney disease (CKD) to spontaneous intracerebral haemorrhage (ICH) is inconclusive owing to possible confounding by comorbidities that frequently coexist in patients with these 2 diseases.

A study was conducted to determine whether there is an association between CKD and ICH risk.

A 3-stage study that combined observational and genetic analyses were conducted. First, the association between CKD and ICH risk was tested in the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) study, a multicenter case-control study in the US. All participants with available data on CKD from ERICH were included. Second, this analysis was replicated in the UK Biobank (UKB), an ongoing population study in the UK. All participants in the UKB were included in this study. Third, mendelian randomization analyses were implemented in the UKB using 27 CKD-related genetic variants to test for genetic associations. ERICH was conducted from August 1, 2010, to August 1, 2017, and observed participants for 1 year. The UKB enrolled participants between 2006 and 2010 and will continue to observe them for 30 years. Data analysis was performed from November 11, 2019, to May 10, 2022.

The outcome of interest was ICH, ascertained in ERICH via expert review of neuroimages and in the UKB via a combination of self-reported data and International Statistical Classification of Diseases, Tenth Revision, codes.

The Results of the study are:

  • In the ERICH study, a total of 2914 participants with ICH and 2954 controls who had available data on CKD were evaluated
  • CKD was found to be independently associated with a higher risk of ICH
  • This association was not modified by race and ethnicity. Replication in the UKB with 1341 participants with ICH and 501 195 controls confirmed this association.
  • Mendelian randomization analyses indicated that genetically determined CKD was associated with ICH risk

Thus, in this 3-stage study that combined observational and genetic analyses among study participants enrolled in 2 large observational studies with different characteristics and study designs, CKD was consistently associated with a higher risk of ICH. Mendelian randomization analyses suggest that this association was causal. Further studies are needed to identify the specific biological pathways that mediate this association.

Reference:

Vanent KN, Leasure AC, Acosta JN, et al. Association of Chronic Kidney Disease With Risk of Intracerebral Hemorrhage. JAMA Neurol. Published online August 15, 2022. doi:10.1001/jamaneurol.2022.2299

Keywords:

Association, Chronic, Kidney, Disease, Risk, Intracerebral, Hemorrhage, jama neurology, Kevin N. Vanent, Audrey C. Leasure, Julian N. Acosta, Lindsey R. Kuohn, Daniel Woo, Santosh B. Murthy, Hooman Kamel, Steven R. Messé, Michael T. Mullen, Jordana B. Cohen, Debbie L. Cohen, Raymond R. Townsend, Nils H. Petersen, Lauren H. Sansing, Thomas M. Gill, Kevin N. Sheth, Guido J. Falcone,


Tags:    
Article Source : JAMA Neurology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News